Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

DVAX 23.47 -0.82 (-3.38%)
price chart
Andrew Gengos out, John Walker in as Neuraltus CEO
Andrew Gengos, who led Neuraltus Pharmaceuticals Inc. into a Phase II trial of its experimental treatment for Lou Gehrig's disease, has left the company. Veteran Bay Area biotech executive John Walker, Neuraltus' chairman, took over Aug. 15 as interim ...
KSW Agrees To Be Acquired By Related Companies For $5/shr In Cash - Quick Facts
KSW, Inc. (KSW), a provider of heating, ventilating and air conditioning systems, announced that it agreed to be acquired by Related Companies , a privately-owned real estate firm in the United States, for $5.00 per share in cash.